Recilisib Sodium | m-entrepreneurship.com

Product Name :
Recilisib Sodium

Search keywords :
Recilisib

drugId :
null

Target Vo:
Protease

Target Vo Short Name :
Protease

Moa_Name:
Apoptosis inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Traws Pharma Inc

Active Company_Name :
Traws Pharma Inc

Active Indication_Name:
Acute Radiation Syndrome

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Lorvotuzumab Biological Activity
Eculizumab Immunology/Inflammation
TRIM21 Antibody (YA658): TRIM21 Antibody (YA658) is a non-conjugated and Mouse origined monoclonal antibody about 54 kDa, targeting to TRIM21 (5B9). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts